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Methods: Fifty cases of infected diabetic foot ulcers were
tudied. Quantitative bacterial cultures on sheep blood agar was
erformed as baseline (prior to treatment) and at 7 and 14 days
ollowing application of silver alginate dressing. Results of quanti-
ative cultures were co-related with clinical improvement in ulcer
ize and local signs of infection. Bacteria isolated were identiﬁed
nd antibiogram was determined as per CLSI guidelines. Killing
urves were recorded by inoculating the surface of silver alginate
ressing with 105 bacteria. Sensitivity and duration of silver ion
ctivity was assessed by placing a 7mm disc of silver ion foam
n nutrient agar. Growth inhibition zone diameters were recorded
y serial transfer of this disc onto freshly inoculated plates for 7
onsecutive days.
Results: Bacteria isolated: S.aureus 32% (28% MRSA), E.coli 24%
39% ESBL+ve, 12% MBL+ve), P.aeruginosa 37% (15% MBL+ve), Enter-
bacter spp 4% and Citrobacter 3%. Killing curves showed sterility
pproximatelyone to2.5hours followingexposure to silver ions.All
he isolateswere sensitive to silver irrespectiveof their antibiogram
tatus. Growth inhibition zone diameters were maintained steady
pto 7 days. In all cases decrease in bacterial load was associated
ith decrease in ulcer size.
Conclusion: This study shows that topical use of silver ions
ould serve as efﬁcient alternative to topical antibiotics in infected
ound management. Silver alginate dressing appears to be effec-
ive in reducing wound bio-burden which is positively associated
ith ulcer healing. As bacterial susceptibility to silver ions is not
eing inﬂuenced by antibiotic resistance in-vitro, we conclude that
ilver ions can be used effectively for treatment of infected ulcers
long with systemic antibiotics.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.601
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acterial bioﬁlms: exploring the emerging link in pathogenesis
nd therapeutic implications among multidrug resistant bacte-
ial isolates
.R. Pusapati1,∗, M.Y. Yusof2, J. Lopez1, N.S. Sabet3
MAHSA University College, Kuala Lumpur, Selangor, Malaysia
Department of Medical Microbiology, Faculty of Medicine, University
alaya, Kuala Lumpur, Malaysia
University of Malaya, Kuala Lumpur, Selangor, Malaysia
Background: Bioﬁlms are matrix-enclosed microbial commu-
ity that adhere to biological or non-biological surfaces and
epresent a signiﬁcant and incompletely understood mode of
rowth for bacteria. Bioﬁlm formation represents a protectedmode
f growth that allows cells to survive in hostile environments
nd also disperse to colonize new niches. The aim of the present
tudy was to determine in vitro antimicrobial susceptibility among
elected multidrug resistant strains isolated from various clinical
amples and to correlate the production of bioﬁlm and their effect
n action on antimicrobial agents in vivo.
Methods: The studywas conducted fromMay 2011 to Aug 2011
t Department of Biomedical Sciences, MAHSA University College.
he multidrug resistant bacterial strains used in the study were
solated fromclinical samples received at theDepartment ofMicro-
iology, Faculty ofMedicine, University ofMalaya. The strainswerefectious Diseases 16S (2012) e317–e473
preserved in refrigeration temperature of 4 ◦C until further use.
Antibiotic susceptibility was performed by the Kirby Bauer disk
diffusion method using guidelines established by the Clinical Labo-
ratory Standard Institute (CLSI). The productions of bioﬁlmby these
multidrug resistant strains were measured by using the well estab-
lishedandsemi-quantitativemicrotitreplate assay thatuses crystal
violet staining.
Results: In this study, 18 (36%) of total 50 multidrug resistant
strains studied showed strong ability in the formation of bioﬁlm
invitro which determines the association between formation of
bioﬁlm by these multidrug resistant strains and its implications
in the treatment of chromic infections.
Conclusion: Most bacteria, given the right conditions, can grow
produce bioﬁlm. Bioﬁlms are responsible for a number of diseases
of man and, because of the intrinsic resistance of these structures
to antibiotics and host defence systems, such diseases are very
difﬁcult to treat effectively. In addition, bacteria within bioﬁlms
have increased (up to 1000-fold higher) resistance to antimicro-
bial compounds, even though these same bacteria are sensitive to
these agents if grown under planktonic conditions. Our results in
the present study suggest that bioﬁlm formation is emerging as
an alternative virulence phenomenon among multidrug resistant
strains for their survival in hostile environments in vivo.
http://dx.doi.org/10.1016/j.ijid.2012.05.602
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Aminoglycoside resistance in clinical isolates of Gram negative
bacilli encountered over a period of 30 years at the University
Hospital of the West Indies, Jamaica
G. Reynolds1,∗, A. Nicholson2
1 Umiversity of the West Indies, Kingston, jm, Jamaica
2 University of the West Indies, Kingston, Jamaica
Background: Aminoglycoside antibiotics have been in use
worldwide for over 60 years. Gentamicin and amikacin are the two
aminoglycosides used commonly in clinical practice. Gentamicin
was introduced at the University Hospital of the West Indies (a 534
bed tertiary care teaching hospital) in Kingston, Jamaica in 1973
and amikacin in 1980. In this report, we examine the susceptibil-
ities to gentamicin and amikacin in 1547 consecutive isolates of
Gramnegative bacilli encountered between 1st Sept. and 30thNov.
2011 and compare the data with those observed in 1981 and 2002
in this hospital.
Methods: The isolates were identiﬁed, MICs were determined
and the susceptibilitieswereascertainedusingVitek2 (bioMerieux,
Durham,NC). Quality controls were done using American Type Cul-
ture standard strains E coli ATCC 25922 and Pseudomona aeruginosa
ATCC 27853.
Results: Resistance to gentamicin in E coli increased from 0.4%
(1981) to 7.3% (2002) and further to 15.6% in 2011. In Klebsiella
pneumoniae it rose from 3.9% (1981) to 16% (2002) and 17.1%
in 2011. Enterobacter resistance to gentamicin moved from 4.3%
(1981) to 12.5% (2002) but dropped to 6.3% in 2011. In Proteus
mirabilis the levels of resistance increased from2.4% (1981) to15.2%
(2002)withminimal decline to 11.6% in 2011. Therewas a dramatic
increase of gentamicin resistance in Acinetobacter from 4% in 1981
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o 54.4% in 2002. However, there was a decrease in the levels of
esistance in Pseudomanas aeruginosa from 18.5% in 1981 to 15.6%
n 2002 and further to 5% in 2011. Overall, the levels of resistance to
entamicin increased from 6.7% in 1981 to 14.8% in 2011 and that
o amikacin increased from merely 0.6% in 1981 to 7.2% in 2011.
Conclusion: Despite continuous usage for over three decades,
ore than 85% of Gram negative bacilli still remain susceptible to
entamicin and amikacin and the compounds continue to remain
ighly effective in the therapy of commonGramnegative infections
n this hospital. Similar observations of slow occurrence of resis-
ance to aminoglycoside antibiotics and a decrease of resistance
specially in isolates of Pseudomonas aeruginosa have been made
y others (Clin Infect Dis 19:819,1994., Int J Antimicrob Agents
6:309,2000).
ttp://dx.doi.org/10.1016/j.ijid.2012.05.603
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eta-lactamases from Lahore, Pakistan
. Riaz ∗
Department of microbiology and molecular genetics, Lahore, Pakistan
Background: Successful spread of ESBL can be attributed to
he fact that genes encoding for ESBL are often located on self-
ransmissible or mobilizable broad range plasmids. There is great
iversity in type of gene producing beta-lactamase, such as TEM,
HV, OXA, PER, VEB, BES, CTX-M and others. Here genotypic dis-
ribution of plasmid encoded extended spectrum Beta-lactamases
rom Lahore, Pakistan were studied.
Methods: DNA Ampliﬁcation for TEM, SHV and OXA-1 encoding
enes was performed using singlplex and multiplex PCR, plasmid
solation, horizontal gene transfer, isoelectric focuing and amino
cids were calculated in local isolates of E.coli and Klebiella spp.
Results: In 260 clinical isolates of E. coli suspected to be ESBL
roducers OXA (19.2%) and TEM/OXA (44.2%) were more preva-
ent. Of the 40 clinical isolates of Klebsiella spp 92.5% demonstrated
HV-speciﬁc products. In 87 environmental isolates of E. coli 58.6%
EM/OXA and out of 13 environmental isolates of Klebsiella spp
xhibited 76.92% SHV. All tested isolates showed high rate of
esistance transfer though horizontal gene transfer mechanism.
solectric focusing was performed that give isoelectric points for
peciﬁc beta-lactamase.
Conclusion:ESBLplasmidencodedgeneswere easily transfered
hrough horizontal gene transfermechanism. The best resultswere
btained fromPCR andDNA sequencing as compared to calculating
solectric points (pI). If somehowmultiplex PCRof ESBLwill applied
n local diagnostic labs this helps in early detection and phenotypic
ntibiotic therapy against this infection.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.604fectious Diseases 16S (2012) e317–e473 e431
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New Delhi metallo--lactamase-1 (NDM-1)-producing Enter-
obacteriaceae: ﬁrst report in Thailand
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N. Charoensri2, P. Sribenjalux2, W. Phumsrikaew3, L.
Wonglakorn3, P. Chetchotisakd4
1 Graduate School, Khon Kaen University, Khon Kaen, Thailand
2 Khon Kaen University, Khon Kaen, Thailand
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4 Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand
Background: Carbapenems are recommended for treatment of
serious infections caused by Gram negative bacilli including ESBL-
or AmpC-producing Enterobacteriaceae. However, carbapenem-
resistant Enterobacteriaceae by production of carbapenemases
have emerged worldwide. In Srinagarind Hospital, ESBL-producing
isolates have been found with high prevalence rates in 2010 (46%
for E. coli and 47% forK. pneumoniae), leading to an increasing use of
carbapenems. Therefore, surveillance of carbapenemases in clinical
isolates of Enterobacteriaceae may contribute useful information
for clinician to select appropriate antimicrobial therapy and for
infection control to prevent the dissemination of these resistant
strains in the hospital.
Methods: A total of 4,818 Enterobacteriaceae isolates collected
from patients in Srinagarind Hospital, Thailand between October
2010 and August 2011 were screened for the presence of car-
bapenemases by ertapenem and imipenem disk diffusion tests. All
positive-screening isolates were subjected to modiﬁed Hodge test,
boronic acid- and EDTA-carbapenem combined disk tests and two
multiplex PCR of blaIMP, blaVIM, blaSPM, blaSIM and blaGIM, and
of blaKPC, blaNDM and blaOXA-48. Carbapenemase-producing iso-
lates were typed by ERIC-PCR and REP-PCR and then characterized
by antimicrobial susceptibility tests. Conjugation was performed
by broth culture mating method.
Results: Six isolates including 2 isolates of each Escherichia coli,
Klebsiella pneumoniae and Citrobacter freundii were found to pro-
duce NDM-1, whereas other 2 isolates of K. pneumoniae produced
IMP-14a. DNA ﬁngerprints revealed that the 8 MBL-producing iso-
lates were of different strains. In vitro transfer of carbapenem
resistance was successful for all MBL-producing isolates, indicat-
ing the ease of transmission of these resistance determinants. MICs
of imipenem, meropenem and ertapenem for the NDM-1 produc-
ers were 4-16 g/ml, 4-16 g/ml and 16-64 g/ml respectively,
whereas those for both IMP-14a producers were 0.25 g/ml, 0.5-
2 g/ml and 2-4 g/ml respectively. All MBL-producing isolates
were susceptible to colistin and tigecycline. The 6 NDM-1 produc-
erswere recovered fromurineof threepatients, thehistoryof travel
outside Thailand was unknown.
Conclusion: Surveillance of these carbapenemases in Enter-
obacteriaceae is urgently needed to control and prevent the spread
of these resistance determinants. The ertapenem disk screening
test in combinationwith the EDTA-carbapenem combined disk test
are recommended for MBL detection in routine laboratory.
http://dx.doi.org/10.1016/j.ijid.2012.05.605
